Switch to Ceftriaxone (Rocephin) Immediately
Based on your culture showing E. coli sensitive to ceftriaxone and cefepime but resistant to cephalexin (intermittent resistance to cefazolin), you should switch to ceftriaxone 1-2g IV/IM daily or cefepime 1-2g IV every 12 hours. 1, 2
Recommended Treatment Based on Infection Severity
For Uncomplicated UTI/Cystitis
- Switch to oral nitrofurantoin 100mg twice daily for 5-7 days if the organism is sensitive and infection is limited to bladder 1, 3
- Alternative: Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days only if local resistance <20% and organism is sensitive 1, 3
- Fosfomycin 3g single dose is another option but may have slightly inferior efficacy 3
For Complicated UTI or Pyelonephritis
- Ceftriaxone 1-2g IV/IM once daily for 10-14 days is the preferred choice given your culture sensitivities 1, 2
- Cefepime 1-2g IV every 12 hours for 10 days is equally appropriate for severe infections 2
- For severe infections with septic shock, carbapenems (meropenem or imipenem) are recommended, though ertapenem may be used without septic shock 1
Critical Decision Points
Why Keflex Failed
- Your E. coli shows intermittent resistance to cefazolin (same class as cephalexin), explaining treatment failure 4
- First-generation cephalosporins like cephalexin have increasing resistance rates in E. coli UTIs 4
- Never continue cephalexin when culture shows cefazolin resistance 1
Antibiotics to AVOID
- Do NOT use ciprofloxacin or levofloxacin - your culture shows fluoroquinolone resistance 1, 3
- Do NOT use ampicillin or amoxicillin - E. coli has 75% median resistance rates globally 1
- Avoid aminoglycosides as monotherapy for anything beyond short-course UTI treatment 1
Treatment Duration Algorithm
For lower UTI (cystitis):
For pyelonephritis:
For men (when prostatitis cannot be excluded):
- Extend treatment to 14 days minimum 3
Antibiotic Stewardship Considerations
- Reserve carbapenems for severe infections or extended-spectrum beta-lactamase (ESBL) producers 1
- Ceftriaxone and cefepime are appropriate for your 3rd-generation cephalosporin-sensitive E. coli without overusing carbapenems 1
- Once clinically stable, consider step-down to oral therapy based on repeat culture sensitivities 1
Common Pitfalls
- Do not empirically use fluoroquinolones if patient used them in last 6 months - resistance risk is high 3
- Do not use cefepime or cefoxitin for ESBL-producing organisms - insufficient evidence for efficacy 1
- Verify renal function before dosing - cefepime requires dose adjustment for creatinine clearance <60 mL/min 2